BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5403099)

  • 1. [Action of 2 new products, thalidomide and B. 663 on reactive forms of Hansen's disease].
    Languillon J
    Med Trop (Mars); 1969; 29(4):497-503. PubMed ID: 5403099
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incorporation of thalidomide to the therapeutic arsenal of Hansen's disease (award of the Spanish Academy of Dermatology 1968)].
    Sheskin J
    Actas Dermosifiliogr; 1969; 60(3):57-72. PubMed ID: 5800285
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
    Rostant MM
    Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
    [No Abstract]   [Full Text] [Related]  

  • 4. Leprosy (Hansen's disease).
    Brazin SA
    Otolaryngol Clin North Am; 1982 Aug; 15(3):597-611. PubMed ID: 6752824
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary of recent abstracts. 8. Leprosy.
    Browne SG
    Trop Dis Bull; 1971 Sep; 68(9):1021-30. PubMed ID: 4943397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of the medical treatment of Hansen's disease].
    Coudert J; Lu HT
    J Med Lyon; 1972 Sep; 53(232):1047-54. PubMed ID: 4638074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early diagnosis, therapy, and research in the control of leprosy].
    Contreras Duenas F
    Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent experience with thalidomide in Hansen's Disease.
    Sheskin J
    Int J Dermatol; 1970; 9(1):56-8. PubMed ID: 4912951
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the therapeutic activity of glutamic acid phthalimide and the therapeutic activity of triamcinolone in the treatment of Hansen's reaction of Virchowian Leprosy].
    de Almeida Neto E
    Hansenol Int; 1981 Dec; 6(2):114-21. PubMed ID: 6759397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hansen's disease update.
    Goodless DR; Johnson AH
    J Fla Med Assoc; 1990 May; 77(5):520-5. PubMed ID: 2351944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leprosy research].
    Luger A
    Wien Klin Wochenschr; 1971 Mar; 83(10):161-5. PubMed ID: 4327066
    [No Abstract]   [Full Text] [Related]  

  • 13. [2 cases of anti-reactive ineffectiveness of thalidomide treatment of leprosy].
    Merklen FP; Cottenot F
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(6):738-9. PubMed ID: 5712976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rapidly resolutive action of thalidomide on recurrences of leprosy].
    Degos R; Lortat-Jacob E; Civatte J; Daniel F
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):474-8. PubMed ID: 5987422
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
    Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hansen L: action of thalidomide on a severe outburst].
    Duperrat B; Puissant A; Goudie ; David V; Saurat JM
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(3):291-2. PubMed ID: 5134979
    [No Abstract]   [Full Text] [Related]  

  • 17. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 18. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders.
    Millrine D; Kishimoto T
    Trends Mol Med; 2017 Apr; 23(4):348-361. PubMed ID: 28285807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of B.663 in human leprosy.
    Atkinson AJ; Sheagren JN; Rubio JB; Knight V
    Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.